Successful lung transplantation using an allograft from a COVID-19–recovered donor: a potential role for subgenomic RNA to guide organ utilization
Open Access
- 11 January 2023
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (1) , 101-107
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Institute of Dental and Craniofacial Research
- National Cancer Institute
- Clinical Center
This publication has 24 references indexed in Scilit:
- Successful double-lung transplantation from a donor previously infected with SARS-CoV-2The Lancet Respiratory Medicine, 2021
- Is it Safe to Be Transplanted From Living Donors Who Recovered From COVID-19? Experience of 31 Kidney Transplants in a Multicenter Cohort Study From IndiaTransplantation, 2020
- SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replicationNature Communications, 2020
- Transmission of SARS-CoV-2 in Domestic CatsNew England Journal of Medicine, 2020
- A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progressionLaboratory Investigation, 2020
- Utilization of deceased donors during a pandemic: argument against using SARS-CoV-2–positive donorsAmerican Journal of Transplantation, 2020
- A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesisPLOS Biology, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Continuous and Discontinuous RNA Synthesis in CoronavirusesAnnual Review of Virology, 2015
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004